Y Intercept (Hong Kong) LTD Charles River Laboratories International, Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $1.52 Million - $1.74 Million
8,293 Added 342.83%
10,712 $2.25 Million
Q1 2023

May 09, 2023
BUY
$191.89 - $259.92 $464,181 - $628,746
2,419 New
2,419 $488,000
Q2 2022

Aug 08, 2022
BUY
$204.13 - $302.4 $964,922 - $1.43 Million
4,727 Added 568.83%
5,558 $1.19 Million
Q1 2022

May 16, 2022
BUY
$255.51 - $362.11 $212,328 - $300,913
831 New
831 $236,000

Others Institutions Holding CRL

# of Institutions
694
Shares Held
52M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email